CN Patent

CN120112517A — 桥环类化合物及其在药学上的应用

Assigned to Medshine Discovery Inc · Expires 2025-06-06 · 1y expired

What this patent protects

本发明公开了一系列桥环类化合物及其在药学上的应用，具体公开了式(I)所示化合物及其药学上可接受的盐。

USPTO Abstract

本发明公开了一系列桥环类化合物及其在药学上的应用，具体公开了式(I)所示化合物及其药学上可接受的盐。

Drugs covered by this patent

Erleada (apalutamide) · Johnson & Johnson

Patent Metadata

Patent number: CN120112517A
Jurisdiction: CN
Classification: —
Expires: 2025-06-06
Drug substance claim: No
Drug product claim: No
Assignee: Medshine Discovery Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.